Hypertension Diagnostics, Inc.
Hypertension Diagnostics, Inc. (HDII) Stock Ownership
Latest 13F position summary is not yet available — breakdown and tables fill in after filings publish (typically ~45 days after quarter end).
SEC 13F · FMP · HDII · as of —
Ownership Breakdown
Institutional data for this period is not yet available. SEC Form 13F filings are typically published 45 days after quarter end.
No institutional data available for this period.
Insider Buying vs Selling
HDII insider trading · insider activity
Source: SEC Form 4
1
Buy transactions
1
Sell transactions
1.00
Buy/Sell ratio
$1M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
BRIMMER KENNETH WILLIAM CEO and CFO | Feb 10, 2012 | Award | 9,062,907 | — | — | 9.25M | Form 4 ↗ |
BRIMMER KENNETH WILLIAM CEO and CFO | Feb 10, 2012 | Gift | 500,000 | — | — | 8.75M | Form 4 ↗ |
GUETTLER GREG H President, Secretary | Dec 16, 2010 | Award | 400,000 | $0.10 | $40.0K | 400.0K | Form 4 ↗ |
BRIMMER KENNETH WILLIAM director | Dec 16, 2010 | Award | 225,000 | $0.10 | $22.5K | 225.0K | Form 4 ↗ |
LEITNER LARRY director | Dec 16, 2010 | Award | 225,000 | $0.10 | $22.5K | 225.0K | Form 4 ↗ |
STERN ALAN director | Dec 16, 2010 | Award | 225,000 | $0.10 | $22.5K | 225.0K | Form 4 ↗ |
COHN JAY N MD director | Dec 16, 2010 | Award | 225,000 | $0.10 | $22.5K | 225.0K | Form 4 ↗ |
HOEKSTRA MARTEN 10 percent owner | Oct 1, 2010 | Award | 712,433 | $0.30 | $213.7K | 712.4K | Form 4 ↗ |
HOEKSTRA MARTEN 10 percent owner | Oct 5, 2010 | D-Return | 151,708 | $0.30 | $45.5K | 560.7K | Form 4 ↗ |
HOEKSTRA MARTEN 10 percent owner | Oct 1, 2010 | Award | 407,105 | $0.22 | $89.6K | 407.1K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Hypertension Diagnostics, Inc. (HDII) is primarily owned by institutional investors, who hold approximately — of total shares outstanding. Company insiders own approximately —, while retail and public investors account for the remaining —.
A total of 0 institutional investors currently hold HDII stock, with a combined institutional value of approximately $0 as of the most recent 13F filing period.
Frequently asked questions
HDII ownershipHypertension Diagnostics, Inc. (HDII) is primarily owned by institutional investors, who hold approximately — of shares. The largest shareholder is — with a — stake. Company insiders hold —. Data sourced from SEC Form 13F as of —.